Endovascular Versus Medical Therapy in Posterior Cerebral Artery Stroke: Role of Baseline NIHSS Score and Occlusion Site

Author:

Strambo Davide1ORCID,Michel Patrik1ORCID,Nguyen Thanh N.23ORCID,Abdalkader Mohamad3ORCID,Qureshi Muhammad M.34ORCID,Strbian Daniel5ORCID,Herweh Christian6ORCID,Möhlenbruch Markus A.6,Räty Silja5ORCID,Olivé-Gadea Marta7,Ribo Marc7,Psychogios Marios8,Fischer Urs910,Nguyen Anh8,Kuramatsu Joji B.11,Haupenthal David11,Köhrmann Martin12,Deuschl Cornelius13,Kühne Escolà Jordi12,Demeestere Jelle1415,Lemmens Robin1415,Vandewalle Lieselotte1415,Yaghi Shadi16,Shu Liqi16,Puetz Volker1718,Kaiser Daniel P.O.1918,Kaesmacher Johannes20,Mujanovic Adnan20,Marterstock Dominique Cornelius21,Engelhorn Tobias21,Requena Manuel19,Dasenbrock Hormuzdiyar H.3,Klein Piers3,Haussen Diogo C.22,Mohammaden Mahmoud H.22,Abdelhamid Hend22,Souza Viana Lorena22,Cunha Bruno23,Fragata Isabel2324,Romoli Michele25,Diana Francesco26,Hu Wei27,Zhang Chao27,Virtanen Pekka28,Lauha Riikka28,Jesser Jessica6,Clark Judith2,Matsoukas Stavros29,Fifi Johanna T.29,Sheth Sunil A.30,Salazar-Marioni Sergio30,Marto João Pedro31,Ramos João Nuno32,Miszczuk Milena33,Riegler Christoph34,Poli Sven3536,Poli Khouloud3536,Jadhav Ashutosh P.37,Desai Shashvat M.37,Maus Volker3839,Kaeder Maximilian38,Siddiqui Adnan H.3,Monteiro Andre40,Masoud Hesham E.41,Suryadareva Neil42,Mokin Maxim43,Thanki Shail43,Alpay Kemal44,Ylikotila Pauli45,Siegler James E.46,Linfante Italo47,Dabus Guilherme47,Asdaghi Negar48,Saini Vasu48,Nolte Christian H.34,Siebert Eberhard33,Serrallach Bettina L.20,Weyland Charlotte S.49,Hanning Uta50,Meyer Lukas50,Berberich Anne51,Ringleb Peter A.52,Nogueira Raul G.42,Nagel Simon

Affiliation:

1. Service of Neurology, Department of Clinical Neurosciences, University Hospital of Lausanne and University of Lausanne, Switzerland (D. Strambo, P.M.).

2. Neurology (T.N.N., J.C.), Boston Medical Center, MA.

3. Radiology (T.N.N., M.A., M.M.Q., P.K., H.D.), Boston Medical Center, MA.

4. Radiation Oncology (M.M.Q.), Boston Medical Center, MA.

5. Neurology (D. Strbian, S.R.), Helsinki University Hospital, University of Helsinki, Finland.

6. Neuroradiology (C.H., M.A.M., J.J.), Heidelberg University Hospital, Germany.

7. Neurology, Hospital Universitario Vall d’Hebron, Barcelona, Spain (M.O.-G., M. Ribo, M. Requena).

8. Radiology, Basel University Hospital, University of Basel, Switzerland (M.P., A.N.).

9. Department of Neurology, University Hospital and University of Bern, Switzerland (U.F.).

10. Department of Neurology, University Hospital and University of Basel, Switzerland (U.F.).

11. Neurology (J.B.K, D.H.), University of Erlangen-Nuremberg, Germany.

12. Neurology, Institute of Diagnostic and Interventional Radiology (M. Köhrmann, J.K.E.), University Hospital Essen, Germany.

13. Neuroradiology (C.D.), University Hospital Essen, Germany.

14. Neurology, UZ Leuven, Belgium (J.D., R. Lemmens, L.V.).

15. Laboratory for Neurobiology, KU Leuven, Belgium (J.D., R. Lemmens, L.V.).

16. Neurology, Rhode Island Hospital (S.Y., L.S.).

17. Neurology (V.P.), University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.

18. Dresden University Stroke Center (V.P., D.P.O.K.), University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.

19. Neuroradiology (D.P.O.K.), University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.

20. Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern Inselspital, University of Bern, Switzerland (J.K., A. Mujanovic, B.S.).

21. Neuroradiology (D.C.M., T.E.), University of Erlangen-Nuremberg, Germany.

22. Neurology, Grady Memorial Hospital (D.C.H., M.H.M., H.A., L.S.V.).

23. Neuroradiology, Centro Hospitalar Universitario de Lisboa Central, Portugal (B.C., I.F.).

24. NOVA Medical School, Universidade Nova de Lisboa, Portugal (I.F.).

25. Neurology and Stroke Unit, Department of Neuroscience, Bufalini Hospital, Cesena, Italy (M. Romoli).

26. Neuroradiology, University Hospital ‘San Giovanni di Dio e Ruggi d’Aragona’, Salerno, Italy (F.D.).

27. Neurology, The First Affiliated Hospital of USTC, Hefei, China (W.H., C.Z.).

28. Radiology (P.V., R. Lauha, K.L.), Helsinki University Hospital, University of Helsinki, Finland.

29. Neurosurgery, Mount Sinai Health System (S.M., J.T.F.).

30. Neurology, McGovern Medical School at UTHealth, TX (S.A.S., S.S.-M.).

31. Neurology (J.P.M.), Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental, Portugal.

32. Neuroradiology (J.N.R.), Hospital de Egas Moniz, Centro Hospitalar Lisboa Ocidental, Portugal.

33. Neuroradiology (M. Miszczuk, E.S.), Charité–Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.

34. Departement of Neurology and Experimental Neurology, and Center for Stroke Research Berlin (C.R., C.H.N.), Charité–Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.

35. Department of Neurology and Stroke (S.P., K.P.), University of Tübingen, Germany.

36. Hertie Institute for Clinical Brain Research (S.P., K.P.), University of Tübingen, Germany.

37. Neurosurgery, Barrow Neurological Institute, Phoenix, AZ (A.P.J., S.M.D.).

38. Radiology, Neuroradiology, and Nuclear Medicine, University Hospital Knappschaftskrankenhaus Bochum, Germany (V.M., M.K.).

39. Institute of Radiology and Neuroradiology, Klinikum Aschaffenburg, Germany (V.M.).

40. Neurosurgery, University of Buffalo, NY (A.H.S., A. Monteiro).

41. Neurology, New York Upstate Medical University (H.E.M.).

42. Neurology, University of Pittsburgh Medical Center, PA (N.S., R.G.N.).

43. Neurosurgery, University of South Florida, Tampa (M. Mokin, S.T.).

44. Radiology (K.A.), Turku University Hospital, Finland.

45. Neurology (P.Y.), Turku University Hospital, Finland.

46. Neurology, University of Chicago, IL (J.E.S.).

47. Miami Neuroscience Institute, FL (I.L., G.D.).

48. Neurology, University of Miami Miller School of Medicine, FL (N.A., V.S.).

49. Neuroradiology, University Hospital RWTH Aachen, Germany (C.S.W.).

50. Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Germany (U.H., L.M.).

51. Neurology, Klinikum Ludwigshafen, Germany (A.B., S.N.).

52. Neurology (P.A.R., S.N.), Heidelberg University Hospital, Germany.

Abstract

BACKGROUND: Acute ischemic stroke with isolated posterior cerebral artery occlusion (iPCAO) lacks management evidence from randomized trials. We aimed to evaluate whether the association between endovascular treatment (EVT) and outcomes in iPCAO acute ischemic stroke is modified by initial stroke severity (baseline National Institutes of Health Stroke Scale [NIHSS]) and arterial occlusion site. METHODS: Based on the multicenter, retrospective, case-control study of consecutive iPCAO acute ischemic stroke patients (PLATO study [Posterior Cerebral Artery Occlusion Stroke]), we assessed the heterogeneity of EVT outcomes compared with medical management (MM) for iPCAO, according to baseline NIHSS score (≤6 versus >6) and occlusion site (P1 versus P2), using multivariable regression modeling with interaction terms. The primary outcome was the favorable shift of 3-month modified Rankin Scale (mRS). Secondary outcomes included excellent outcome (mRS score 0–1), functional independence (mRS score 0–2), symptomatic intracranial hemorrhage, and mortality. RESULTS: From 1344 patients assessed for eligibility, 1059 were included (median age, 74 years; 43.7% women; 41.3% had intravenous thrombolysis): 364 receiving EVT and 695 receiving MM. Baseline stroke severity did not modify the association of EVT with 3-month mRS distribution ( P interaction =0.312) but did with functional independence ( P interaction =0.010), with a similar trend on excellent outcome ( P interaction =0.069). EVT was associated with more favorable outcomes than MM in patients with baseline NIHSS score >6 (mRS score 0–1, 30.6% versus 17.7%; adjusted odds ratio [aOR], 2.01 [95% CI, 1.22–3.31]; mRS score 0 to 2, 46.1% versus 31.9%; aOR, 1.64 [95% CI, 1.08–2.51]) but not in those with NIHSS score ≤6 (mRS score 0–1, 43.8% versus 46.3%; aOR, 0.90 [95% CI, 0.49–1.64]; mRS score 0–2, 65.3% versus 74.3%; aOR, 0.55 [95% CI, 0.30–1.0]). EVT was associated with more symptomatic intracranial hemorrhage regardless of baseline NIHSS score ( P interaction =0.467), while the mortality increase was more pronounced in patients with NIHSS score ≤6 ( P interaction =0.044; NIHSS score ≤6: aOR, 7.95 [95% CI, 3.11–20.28]; NIHSS score >6: aOR, 1.98 [95% CI, 1.08–3.65]). Arterial occlusion site did not modify the association of EVT with outcomes compared with MM. CONCLUSIONS: Baseline clinical stroke severity, rather than the occlusion site, may be an important modifier of the association between EVT and outcomes in iPCAO. Only severely affected patients with iPCAO (NIHSS score >6) had more favorable disability outcomes with EVT than MM, despite increased mortality and symptomatic intracranial hemorrhage.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3